Herceptin (Trastuzumab)

Biosimilar Characterization Considerations

Structural Characterization

Physicochemical Characterization

Functional Testing by Custom Biologics

  • Antibody-Dependent Cell Cytotoxicity (ADCC) Reporter Bioassay
  • Complement-Dependent Cytotoxicity (CDC) Assay
  • ELISA
  • Affinity Binding Assay
  • Proliferation Inhibition Assay

Product Specific Technical Considerations

Need Biosimilar Testing?